Pharma & Healthcare
Global Immune Checkpoint Agents Market Research Report 2024
- Mar 19, 24
- ID: 66149
- Pages: 73
- Figures: 152
- Views: 17
Immune Checkpoint Agents are a class of drugs used in cancer treatment that help the body fight cancer cells by modulating the function of the immune system. Immune checkpoints are biological mechanisms that help maintain the balance of the immune system and prevent it from attacking normal cells. However, some cancer cells can use this mechanism to evade immune system attack.
The global Immune Checkpoint Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immune Checkpoint Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Checkpoint Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immune Checkpoint Agents include Bristol Myers Squibb, Merck, AstraZeneca and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Checkpoint Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Checkpoint Agents.
Report Scope
The Immune Checkpoint Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Checkpoint Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Checkpoint Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
Merck
AstraZeneca
Roche
Segment by Type
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
Segment by Application
Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Checkpoint Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Checkpoint Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Immune Checkpoint Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immune Checkpoint Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Checkpoint Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immune Checkpoint Agents include Bristol Myers Squibb, Merck, AstraZeneca and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Checkpoint Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Checkpoint Agents.
Report Scope
The Immune Checkpoint Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Checkpoint Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Checkpoint Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
Merck
AstraZeneca
Roche
Segment by Type
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
Segment by Application
Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Checkpoint Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Checkpoint Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Immune Checkpoint Agents Market Overview
1.1 Product Overview and Scope of Immune Checkpoint Agents
1.2 Immune Checkpoint Agents Segment by Type
1.2.1 Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030)
1.2.2 Anti-PD-L1 Drug
1.2.3 Anti-PD-1 Drug
1.2.4 CTLA4
1.3 Immune Checkpoint Agents Segment by Application
1.3.1 Global Immune Checkpoint Agents Market Value by Application: (2024-2030)
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 BreastCancer
1.3.5 Prostate Cancer
1.3.6 Melanoma
1.3.7 Blood Cancers
1.4 Global Immune Checkpoint Agents Market Size Estimates and Forecasts
1.4.1 Global Immune Checkpoint Agents Revenue 2019-2030
1.4.2 Global Immune Checkpoint Agents Sales 2019-2030
1.4.3 Global Immune Checkpoint Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immune Checkpoint Agents Market Competition by Manufacturers
2.1 Global Immune Checkpoint Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immune Checkpoint Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immune Checkpoint Agents Average Price by Manufacturers (2019-2024)
2.4 Global Immune Checkpoint Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Checkpoint Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Checkpoint Agents, Product Type & Application
2.7 Immune Checkpoint Agents Market Competitive Situation and Trends
2.7.1 Immune Checkpoint Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Checkpoint Agents Players Market Share by Revenue
2.7.3 Global Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Checkpoint Agents Retrospective Market Scenario by Region
3.1 Global Immune Checkpoint Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immune Checkpoint Agents Global Immune Checkpoint Agents Sales by Region: 2019-2030
3.2.1 Global Immune Checkpoint Agents Sales by Region: 2019-2024
3.2.2 Global Immune Checkpoint Agents Sales by Region: 2025-2030
3.3 Global Immune Checkpoint Agents Global Immune Checkpoint Agents Revenue by Region: 2019-2030
3.3.1 Global Immune Checkpoint Agents Revenue by Region: 2019-2024
3.3.2 Global Immune Checkpoint Agents Revenue by Region: 2025-2030
3.4 North America Immune Checkpoint Agents Market Facts & Figures by Country
3.4.1 North America Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immune Checkpoint Agents Sales by Country (2019-2030)
3.4.3 North America Immune Checkpoint Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immune Checkpoint Agents Market Facts & Figures by Country
3.5.1 Europe Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immune Checkpoint Agents Sales by Country (2019-2030)
3.5.3 Europe Immune Checkpoint Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Checkpoint Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immune Checkpoint Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Immune Checkpoint Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immune Checkpoint Agents Market Facts & Figures by Country
3.7.1 Latin America Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immune Checkpoint Agents Sales by Country (2019-2030)
3.7.3 Latin America Immune Checkpoint Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Checkpoint Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immune Checkpoint Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immune Checkpoint Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immune Checkpoint Agents Sales by Type (2019-2030)
4.1.1 Global Immune Checkpoint Agents Sales by Type (2019-2024)
4.1.2 Global Immune Checkpoint Agents Sales by Type (2025-2030)
4.1.3 Global Immune Checkpoint Agents Sales Market Share by Type (2019-2030)
4.2 Global Immune Checkpoint Agents Revenue by Type (2019-2030)
4.2.1 Global Immune Checkpoint Agents Revenue by Type (2019-2024)
4.2.2 Global Immune Checkpoint Agents Revenue by Type (2025-2030)
4.2.3 Global Immune Checkpoint Agents Revenue Market Share by Type (2019-2030)
4.3 Global Immune Checkpoint Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immune Checkpoint Agents Sales by Application (2019-2030)
5.1.1 Global Immune Checkpoint Agents Sales by Application (2019-2024)
5.1.2 Global Immune Checkpoint Agents Sales by Application (2025-2030)
5.1.3 Global Immune Checkpoint Agents Sales Market Share by Application (2019-2030)
5.2 Global Immune Checkpoint Agents Revenue by Application (2019-2030)
5.2.1 Global Immune Checkpoint Agents Revenue by Application (2019-2024)
5.2.2 Global Immune Checkpoint Agents Revenue by Application (2025-2030)
5.2.3 Global Immune Checkpoint Agents Revenue Market Share by Application (2019-2030)
5.3 Global Immune Checkpoint Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Immune Checkpoint Agents Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Immune Checkpoint Agents Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Immune Checkpoint Agents Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Immune Checkpoint Agents Product Portfolio
6.4.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Checkpoint Agents Industry Chain Analysis
7.2 Immune Checkpoint Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Checkpoint Agents Production Mode & Process
7.4 Immune Checkpoint Agents Sales and Marketing
7.4.1 Immune Checkpoint Agents Sales Channels
7.4.2 Immune Checkpoint Agents Distributors
7.5 Immune Checkpoint Agents Customers
8 Immune Checkpoint Agents Market Dynamics
8.1 Immune Checkpoint Agents Industry Trends
8.2 Immune Checkpoint Agents Market Drivers
8.3 Immune Checkpoint Agents Market Challenges
8.4 Immune Checkpoint Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Immune Checkpoint Agents
1.2 Immune Checkpoint Agents Segment by Type
1.2.1 Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030)
1.2.2 Anti-PD-L1 Drug
1.2.3 Anti-PD-1 Drug
1.2.4 CTLA4
1.3 Immune Checkpoint Agents Segment by Application
1.3.1 Global Immune Checkpoint Agents Market Value by Application: (2024-2030)
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 BreastCancer
1.3.5 Prostate Cancer
1.3.6 Melanoma
1.3.7 Blood Cancers
1.4 Global Immune Checkpoint Agents Market Size Estimates and Forecasts
1.4.1 Global Immune Checkpoint Agents Revenue 2019-2030
1.4.2 Global Immune Checkpoint Agents Sales 2019-2030
1.4.3 Global Immune Checkpoint Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immune Checkpoint Agents Market Competition by Manufacturers
2.1 Global Immune Checkpoint Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immune Checkpoint Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immune Checkpoint Agents Average Price by Manufacturers (2019-2024)
2.4 Global Immune Checkpoint Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Checkpoint Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Checkpoint Agents, Product Type & Application
2.7 Immune Checkpoint Agents Market Competitive Situation and Trends
2.7.1 Immune Checkpoint Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Checkpoint Agents Players Market Share by Revenue
2.7.3 Global Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Checkpoint Agents Retrospective Market Scenario by Region
3.1 Global Immune Checkpoint Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immune Checkpoint Agents Global Immune Checkpoint Agents Sales by Region: 2019-2030
3.2.1 Global Immune Checkpoint Agents Sales by Region: 2019-2024
3.2.2 Global Immune Checkpoint Agents Sales by Region: 2025-2030
3.3 Global Immune Checkpoint Agents Global Immune Checkpoint Agents Revenue by Region: 2019-2030
3.3.1 Global Immune Checkpoint Agents Revenue by Region: 2019-2024
3.3.2 Global Immune Checkpoint Agents Revenue by Region: 2025-2030
3.4 North America Immune Checkpoint Agents Market Facts & Figures by Country
3.4.1 North America Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immune Checkpoint Agents Sales by Country (2019-2030)
3.4.3 North America Immune Checkpoint Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immune Checkpoint Agents Market Facts & Figures by Country
3.5.1 Europe Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immune Checkpoint Agents Sales by Country (2019-2030)
3.5.3 Europe Immune Checkpoint Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Checkpoint Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immune Checkpoint Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Immune Checkpoint Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immune Checkpoint Agents Market Facts & Figures by Country
3.7.1 Latin America Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immune Checkpoint Agents Sales by Country (2019-2030)
3.7.3 Latin America Immune Checkpoint Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Checkpoint Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Checkpoint Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immune Checkpoint Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immune Checkpoint Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immune Checkpoint Agents Sales by Type (2019-2030)
4.1.1 Global Immune Checkpoint Agents Sales by Type (2019-2024)
4.1.2 Global Immune Checkpoint Agents Sales by Type (2025-2030)
4.1.3 Global Immune Checkpoint Agents Sales Market Share by Type (2019-2030)
4.2 Global Immune Checkpoint Agents Revenue by Type (2019-2030)
4.2.1 Global Immune Checkpoint Agents Revenue by Type (2019-2024)
4.2.2 Global Immune Checkpoint Agents Revenue by Type (2025-2030)
4.2.3 Global Immune Checkpoint Agents Revenue Market Share by Type (2019-2030)
4.3 Global Immune Checkpoint Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immune Checkpoint Agents Sales by Application (2019-2030)
5.1.1 Global Immune Checkpoint Agents Sales by Application (2019-2024)
5.1.2 Global Immune Checkpoint Agents Sales by Application (2025-2030)
5.1.3 Global Immune Checkpoint Agents Sales Market Share by Application (2019-2030)
5.2 Global Immune Checkpoint Agents Revenue by Application (2019-2030)
5.2.1 Global Immune Checkpoint Agents Revenue by Application (2019-2024)
5.2.2 Global Immune Checkpoint Agents Revenue by Application (2025-2030)
5.2.3 Global Immune Checkpoint Agents Revenue Market Share by Application (2019-2030)
5.3 Global Immune Checkpoint Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Immune Checkpoint Agents Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Immune Checkpoint Agents Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Immune Checkpoint Agents Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Immune Checkpoint Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Immune Checkpoint Agents Product Portfolio
6.4.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Checkpoint Agents Industry Chain Analysis
7.2 Immune Checkpoint Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Checkpoint Agents Production Mode & Process
7.4 Immune Checkpoint Agents Sales and Marketing
7.4.1 Immune Checkpoint Agents Sales Channels
7.4.2 Immune Checkpoint Agents Distributors
7.5 Immune Checkpoint Agents Customers
8 Immune Checkpoint Agents Market Dynamics
8.1 Immune Checkpoint Agents Industry Trends
8.2 Immune Checkpoint Agents Market Drivers
8.3 Immune Checkpoint Agents Market Challenges
8.4 Immune Checkpoint Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Immune Checkpoint Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Immune Checkpoint Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Immune Checkpoint Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Immune Checkpoint Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Immune Checkpoint Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Immune Checkpoint Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Immune Checkpoint Agents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Immune Checkpoint Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Immune Checkpoint Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Checkpoint Agents, Product Type & Application
Table 12. Global Key Manufacturers of Immune Checkpoint Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Checkpoint Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Checkpoint Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Checkpoint Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Immune Checkpoint Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Immune Checkpoint Agents Sales Market Share by Region (2019-2024)
Table 19. Global Immune Checkpoint Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Immune Checkpoint Agents Sales Market Share by Region (2025-2030)
Table 21. Global Immune Checkpoint Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Immune Checkpoint Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Immune Checkpoint Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Immune Checkpoint Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Immune Checkpoint Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Immune Checkpoint Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Immune Checkpoint Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Immune Checkpoint Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Immune Checkpoint Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Immune Checkpoint Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Immune Checkpoint Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Immune Checkpoint Agents Sales Market Share by Type (2019-2024)
Table 53. Global Immune Checkpoint Agents Sales Market Share by Type (2025-2030)
Table 54. Global Immune Checkpoint Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Immune Checkpoint Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Immune Checkpoint Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Immune Checkpoint Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2019-2024)
Table 59. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2025-2030)
Table 60. Global Immune Checkpoint Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Immune Checkpoint Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Immune Checkpoint Agents Sales Market Share by Application (2019-2024)
Table 63. Global Immune Checkpoint Agents Sales Market Share by Application (2025-2030)
Table 64. Global Immune Checkpoint Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Immune Checkpoint Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Immune Checkpoint Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Immune Checkpoint Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2019-2024)
Table 69. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb Immune Checkpoint Agents Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Immune Checkpoint Agents Product
Table 79. Merck Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. AstraZeneca Immune Checkpoint Agents Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Roche Immune Checkpoint Agents Product
Table 89. Roche Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Immune Checkpoint Agents Distributors List
Table 93. Immune Checkpoint Agents Customers List
Table 94. Immune Checkpoint Agents Market Trends
Table 95. Immune Checkpoint Agents Market Drivers
Table 96. Immune Checkpoint Agents Market Challenges
Table 97. Immune Checkpoint Agents Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Immune Checkpoint Agents
Figure 2. Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Immune Checkpoint Agents Market Share by Type in 2023 & 2030
Figure 4. Anti-PD-L1 Drug Product Picture
Figure 5. Anti-PD-1 Drug Product Picture
Figure 6. CTLA4 Product Picture
Figure 7. Global Immune Checkpoint Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Immune Checkpoint Agents Market Share by Application in 2023 & 2030
Figure 9. Lung Cancer
Figure 10. Colorectal Cancer
Figure 11. BreastCancer
Figure 12. Prostate Cancer
Figure 13. Melanoma
Figure 14. Blood Cancers
Figure 15. Global Immune Checkpoint Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Immune Checkpoint Agents Market Size (2019-2030) & (US$ Million)
Figure 17. Global Immune Checkpoint Agents Sales (2019-2030) & (K Units)
Figure 18. Global Immune Checkpoint Agents Average Price (USD/Unit) & (2019-2030)
Figure 19. Immune Checkpoint Agents Report Years Considered
Figure 20. Immune Checkpoint Agents Sales Share by Manufacturers in 2023
Figure 21. Global Immune Checkpoint Agents Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Immune Checkpoint Agents Players: Market Share by Revenue in 2023
Figure 23. Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Immune Checkpoint Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 26. North America Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 30. Europe Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 31. Germany Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Immune Checkpoint Agents Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Immune Checkpoint Agents Revenue Market Share by Region (2019-2030)
Figure 38. China Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 49. Latin America Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. U.A.E Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Immune Checkpoint Agents by Type (2019-2030)
Figure 59. Global Revenue Market Share of Immune Checkpoint Agents by Type (2019-2030)
Figure 60. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Immune Checkpoint Agents by Application (2019-2030)
Figure 62. Global Revenue Market Share of Immune Checkpoint Agents by Application (2019-2030)
Figure 63. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2019-2030)
Figure 64. Immune Checkpoint Agents Value Chain
Figure 65. Immune Checkpoint Agents Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Immune Checkpoint Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Immune Checkpoint Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Immune Checkpoint Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Immune Checkpoint Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Immune Checkpoint Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Immune Checkpoint Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Immune Checkpoint Agents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Immune Checkpoint Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Immune Checkpoint Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Checkpoint Agents, Product Type & Application
Table 12. Global Key Manufacturers of Immune Checkpoint Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Checkpoint Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Checkpoint Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Checkpoint Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Immune Checkpoint Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Immune Checkpoint Agents Sales Market Share by Region (2019-2024)
Table 19. Global Immune Checkpoint Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Immune Checkpoint Agents Sales Market Share by Region (2025-2030)
Table 21. Global Immune Checkpoint Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Immune Checkpoint Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Immune Checkpoint Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Immune Checkpoint Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Immune Checkpoint Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Immune Checkpoint Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Immune Checkpoint Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Immune Checkpoint Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Immune Checkpoint Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Immune Checkpoint Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Immune Checkpoint Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Immune Checkpoint Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Immune Checkpoint Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Immune Checkpoint Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Immune Checkpoint Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Immune Checkpoint Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Immune Checkpoint Agents Sales Market Share by Type (2019-2024)
Table 53. Global Immune Checkpoint Agents Sales Market Share by Type (2025-2030)
Table 54. Global Immune Checkpoint Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Immune Checkpoint Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Immune Checkpoint Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Immune Checkpoint Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2019-2024)
Table 59. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2025-2030)
Table 60. Global Immune Checkpoint Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Immune Checkpoint Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Immune Checkpoint Agents Sales Market Share by Application (2019-2024)
Table 63. Global Immune Checkpoint Agents Sales Market Share by Application (2025-2030)
Table 64. Global Immune Checkpoint Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Immune Checkpoint Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Immune Checkpoint Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Immune Checkpoint Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2019-2024)
Table 69. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb Immune Checkpoint Agents Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Immune Checkpoint Agents Product
Table 79. Merck Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. AstraZeneca Immune Checkpoint Agents Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Immune Checkpoint Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Roche Immune Checkpoint Agents Product
Table 89. Roche Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Immune Checkpoint Agents Distributors List
Table 93. Immune Checkpoint Agents Customers List
Table 94. Immune Checkpoint Agents Market Trends
Table 95. Immune Checkpoint Agents Market Drivers
Table 96. Immune Checkpoint Agents Market Challenges
Table 97. Immune Checkpoint Agents Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Immune Checkpoint Agents
Figure 2. Global Immune Checkpoint Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Immune Checkpoint Agents Market Share by Type in 2023 & 2030
Figure 4. Anti-PD-L1 Drug Product Picture
Figure 5. Anti-PD-1 Drug Product Picture
Figure 6. CTLA4 Product Picture
Figure 7. Global Immune Checkpoint Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Immune Checkpoint Agents Market Share by Application in 2023 & 2030
Figure 9. Lung Cancer
Figure 10. Colorectal Cancer
Figure 11. BreastCancer
Figure 12. Prostate Cancer
Figure 13. Melanoma
Figure 14. Blood Cancers
Figure 15. Global Immune Checkpoint Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Immune Checkpoint Agents Market Size (2019-2030) & (US$ Million)
Figure 17. Global Immune Checkpoint Agents Sales (2019-2030) & (K Units)
Figure 18. Global Immune Checkpoint Agents Average Price (USD/Unit) & (2019-2030)
Figure 19. Immune Checkpoint Agents Report Years Considered
Figure 20. Immune Checkpoint Agents Sales Share by Manufacturers in 2023
Figure 21. Global Immune Checkpoint Agents Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Immune Checkpoint Agents Players: Market Share by Revenue in 2023
Figure 23. Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Immune Checkpoint Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 26. North America Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 30. Europe Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 31. Germany Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Immune Checkpoint Agents Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Immune Checkpoint Agents Revenue Market Share by Region (2019-2030)
Figure 38. China Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 49. Latin America Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Immune Checkpoint Agents Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Immune Checkpoint Agents Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. U.A.E Immune Checkpoint Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Immune Checkpoint Agents by Type (2019-2030)
Figure 59. Global Revenue Market Share of Immune Checkpoint Agents by Type (2019-2030)
Figure 60. Global Immune Checkpoint Agents Price (USD/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Immune Checkpoint Agents by Application (2019-2030)
Figure 62. Global Revenue Market Share of Immune Checkpoint Agents by Application (2019-2030)
Figure 63. Global Immune Checkpoint Agents Price (USD/Unit) by Application (2019-2030)
Figure 64. Immune Checkpoint Agents Value Chain
Figure 65. Immune Checkpoint Agents Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232